You are using an older browser version. Please use a supported version for the best MSN experience.

FDA approves drug to treat postpartum depression

The U.S. Food and Drug Administration has approved the first drug specifically developed to treat postpartum depression. The agency on Tuesday approved Sage Therapeutics' Zulresso, a physician administered IV drug given over 2 ½ days. (March 20)
image beaconimage beaconimage beacon